Aclaris Therapeutics (ACRS) Stock Price
$1.26 0%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
1 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Aclaris Therapeutics, AI stock picks, stock alerts and much more.
ACRS AI Stock Analysis
AI stock analysis for ACRS is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Aclaris Therapeutics (ACRS) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Aclaris Therapeutics (ACRS) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Aclaris Therapeutics (ACRS), currently trading at $1.26, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About ACRS
-
Aclaris Therapeutics, Inc.
-
Symbol
ACRS
-
Market
NASDAQ
-
Industry
Medical - Diagnostics & Research
-
Market Cap
136.4M
Similar Stocks
 |
Bionano Genomics BNGO |
$3.84 0.4% |
3 |
 |
Illumina ILMN |
$75.83 4.7% |
4 |
 |
Neogen NEOG |
$5.97 0.3% |
4 |
 |
DarioHealth DRIO |
$0.7499 7.1% |
5 |
 |
Idexx Laboratories IDXX |
$491.7 0.4% |
7 |
News
ACRS Alternative Data
Web Traffic
Aclaris Therapeutics receives an estimated 4307 monthly visitors to aclaristx.com, which is down by -61.5% over the last month.
-
Web Traffic
4307
-
Change from Previous Month
61.5%
-
3 Month Change
23.3%
-
YoY Change
23.3%
LinkedIn Followers
8,049 are following Aclaris Therapeutics on LinkedIn, up by 1.9% over the last month.
-
LinkedIn Followers
8049
-
Daily Change
0%
-
1 Month Change
1.9%
-
3 Month Change
3.2%
Job Postings
Aclaris Therapeutics currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Aclaris Therapeutics has 58 employees, up by 9.4% over the last month.
-
LinkedIn Employees
58
-
Daily Change
1.8%
-
1 Month Change
9.4%
-
3 Month Change
13.7%
-
YoY Change
13.7%
Reddit Mentions
Aclaris Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
News Mentions
Aclaris Therapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Aclaris Therapeutics is 48 out of 100 (neutral).
-
Business Outlook
48
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
ACRS Financials
ACRS Key Metrics
-
Total Revenue
$9.2M
-
Net Income
-$96.6M
-
Earnings per Share
-$1.21
-
Free cash flow
-$8.9M
-
EBITDA
-$103.8M
-
EBITDA Ratio
-7.58184
-
Total Assets
$220.3M
ACRS 2-year Revenue & Income
ACRS 2-year Free Cash Flow
ACRS Technicals
ACRS SMA
ACRS RSI
FAQ
What's the current price of Aclaris Therapeutics (ACRS) Stock?
The price of an Aclaris Therapeutics (ACRS) share is $1.26.
What's the market cap of Aclaris Therapeutics?
The current market cap of Aclaris Therapeutics is 136.4M.
Should I buy or sell ACRS?
Aclaris Therapeutics exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Aclaris Therapeutics a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Aclaris Therapeutics stock. There are several bearish signals and market challenges that could negatively impact Aclaris Therapeutics' future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Aclaris Therapeutics (ACRS) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Aclaris Therapeutics stock right now, as the outlook appears bearish.
What are some stocks similar to Aclaris Therapeutics (ACRS) that investors often compare it to?
Aclaris Therapeutics (ACRS) is often compared to similar stocks such as Bionano Genomics, Illumina, Neogen, DarioHealth and Idexx Laboratories.
What is the forecast for Aclaris Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Aclaris Therapeutics' stock price to be around $1.13 in 2026. Starting from the current price of $1.26, this represents a 10.3% change in price, indicating a bearish outlook for the stock.
How to buy Aclaris Therapeutics (ACRS) Stock?
Aclaris Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Aclaris Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.